Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices The HeartMate II Risk Score
Jennifer A Cowger,Kartik S. Sundareswaran,Joseph G. Rogers,Soon J. Park,Francis D. Pagani,Geetha Bhat,Brian E. Jaski,David J. Farrar,Mark S. Slaughter +8 more
TLDR
A model to predict survival in candidates for HeartMate II (HMII) left ventricular assist device (LVAD) support was derived and may serve as an additional tool in the patient selection process.About:
This article is published in Journal of the American College of Cardiology.The article was published on 2013-01-22 and is currently open access. It has received 287 citations till now. The article focuses on the topics: Destination therapy.read more
Citations
More filters
Journal ArticleDOI
Advanced heart failure : a position statement of the Heart Failure Association of the European Society of Cardiology
María G. Crespo-Leiro,Marco Metra,Lars H. Lund,Davor Milicic,Maria Rosa Costanzo,Gerasimos Filippatos,Finn Gustafsson,Steven Tsui,Eduardo Barge-Caballero,Nicolaas de Jonge,Maria Frigerio,Righab Hamdan,Tal Hasin,Martin Hülsmann,Sanem Nalbantgil,Luciano Potena,Johann Bauersachs,A. Gkouziouta,Arjang Ruhparwar,Arsen D. Ristić,Ewa Straburzyńska-Migaj,Theresa McDonagh,Petar M. Seferović,Frank Ruschitzka +23 more
TL;DR: There is an urgent need to develop evidence‐based treatment algorithms to prolong life when possible and in accordance with patient preferences, increase life quality, and reduce the burden of hospitalization in this vulnerable patient population.
Journal ArticleDOI
Advanced (stage D) heart failure: A statement from the heart failure society of america guidelines committee
James C. Fang,Gregory A. Ewald,Larry A. Allen,Javed Butler,Cheryl A. Westlake Canary,Monica Colvin-Adams,Michael G. Dickinson,Phillip D. Levy,Wendy Gattis Stough,Nancy K. Sweitzer,John R. Teerlink,David J. Whellan,Nancy M. Albert,Rajan Krishnamani,Michael W. Rich,Mary Norine Walsh,Mark R. Bonnell,Peter E. Carson,Michael C. Chan,Daniel L. Dries,Adrian F. Hernandez,Ray E. Hershberger,Stuart D. Katz,Stephanie A. Moore,Jo E. Rodgers,Joseph G. Rogers,Amanda R. Vest,Michael M. Givertz +27 more
TL;DR: It is proposed that stage D advanced heart failure be defined as the presence of progressive and/or persistent severe signs and symptoms of heart failure despite optimized medical, surgical, and device therapy.
Journal ArticleDOI
Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: A prospective study using the INTERMACS registry (interagency registry for mechanically assisted circulatory support)
Ulrich P. Jorde,Sudhir S. Kushwaha,Antone Tatooles,Yoshifumi Naka,Geetha Bhat,James W. Long,Douglas A. Horstmanshof,Robert L. Kormos,Jeffrey J. Teuteberg,Mark S. Slaughter,Emma J. Birks,David J. Farrar,Soon J. Park,HeartMate Ii Clinical Investigators +13 more
TL;DR: Results in a commercial patient care setting for the DT population supported the original pivotal clinical trial findings regarding the efficacy and risk profile of the HM II LVAD.
Journal ArticleDOI
Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.
Finn Gustafsson,Joseph G. Rogers +1 more
TL;DR: Outcome after LVAD implantation in stable patients is superior to that of ‘crash and burn’ patients or patients sliding on inotropes, favouring early referral and implantation, and current outcomes clearly justify use of LVADs in advanced HF.
Journal ArticleDOI
Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant.
Donna Mancini,Paolo C. Colombo +1 more
TL;DR: Left ventricular assist devices are becoming an increasingly prevalent therapy for patients with Stage D heart failure with reduced ejection fraction and are frequently serving as a substitute for transplant, particularly in the elderly patient.
References
More filters
Journal ArticleDOI
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
TL;DR: A nonparametric approach to the analysis of areas under correlated ROC curves is presented, by using the theory on generalized U-statistics to generate an estimated covariance matrix.
Journal ArticleDOI
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Eric A. Rose,Annetine C. Gelijns,Alan J. Moskowitz,Daniel F. Heitjan,L.W. Stevenson,W Dembitsky,J W Long,D D Ascheim,Anita R. Tierney,R G Levitan,John T. Watson,P Meier,Nuala S. Ronan,P A Shapiro,Ronald M. Lazar,Leslie W. Miller,L Gupta,O.H. Frazier,Patrice Desvigne-Nickens,Mehmet C. Oz,V L Poirier +20 more
TL;DR: The use of a left ventricular assist device in patients with advanced heart failure resulted in a clinically meaningful survival benefit and an improved quality of life.
Journal ArticleDOI
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
Mark S. Slaughter,Joseph G. Rogers,Carmelo A. Milano,Stuart D. Russell,John V. Conte,David S. Feldman,Benjamin Sun,Antone Tatooles,Reynolds M. Delgado,James W. Long,Thomas C. Wozniak,Waqas Ghumman,David J. Farrar,O. Howard Frazier +13 more
TL;DR: Treatment with a continuous-flow left ventricular assist device in patients with advanced heart failure significantly improved the probability of survival free from stroke and device failure at 2 years as compared with a pulsatile device.
Journal ArticleDOI
Shared Decision Making — The Pinnacle of Patient-Centered Care
TL;DR: The most important attribute of patient-centered care is the active engagement of patients when fateful health care decisions must be made when they arrive at a crossroads of medical options, where diverging paths have different and important consequences.
Journal ArticleDOI
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
Leslie W. Miller,Leslie W. Miller,Francis D. Pagani,Stuart D. Russell,Ranjit John,Andrew J. Boyle,Keith D. Aaronson,John V. Conte,Yoshifumi Naka,Donna Mancini,Reynolds M. Delgado,Thomas E. MacGillivray,David J. Farrar,O.H. Frazier +13 more
TL;DR: A continuous-flow left ventricular assist device can provide effective hemodynamic support for a period of at least 6 months in patients awaiting heart transplantation, with improved functional status and quality of life.
Related Papers (5)
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Eric A. Rose,Annetine C. Gelijns,Alan J. Moskowitz,Daniel F. Heitjan,L.W. Stevenson,W Dembitsky,J W Long,D D Ascheim,Anita R. Tierney,R G Levitan,John T. Watson,P Meier,Nuala S. Ronan,P A Shapiro,Ronald M. Lazar,Leslie W. Miller,L Gupta,O.H. Frazier,Patrice Desvigne-Nickens,Mehmet C. Oz,V L Poirier +20 more